# Single Dose Study With Unlabeled Dose and 14C-labeled Microdose of PF-06700841 in Healthy Male Subjects

> **NCT03770039** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 6 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** Oral PF-06700841 containing 14C microtracer
- **DRUG:** Oral unlabeled PF-06700841
- **DRUG:** IV 14C-labeled PF-06700841

## Key facts

- **NCT ID:** NCT03770039
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-10
- **Primary completion:** 2019-02-21
- **Final completion:** 2019-02-21
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03770039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03770039, "Single Dose Study With Unlabeled Dose and 14C-labeled Microdose of PF-06700841 in Healthy Male Subjects". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT03770039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*